首页> 外文期刊>Clinical and Experimental Vaccine Research >Zoonotic infections with avian influenza A viruses and vaccine preparedness: a game of
【24h】

Zoonotic infections with avian influenza A viruses and vaccine preparedness: a game of

机译:甲型禽流感病毒的人畜共患感染和疫苗准备工作:

获取原文
           

摘要

Various direct avian-to-human transmissions of influenza A virus subtypes upon exposure to infected poultry have been previously observed in the past decades. Although some of these strains caused lethal infections, the lack of sustained person-to-person transmission has been the major factor that prevented these viruses from causing new pandemics. In 2013, three (A/H7N9, A/H6N1, and A/H10N8) novel avian influenza viruses (AIVs) yet again breached the animal-human host species barrier in Asia. Notably, roughly 20% of the A/H7N9-infected patients succumbed to the zoonotic infection whereas two of three A/H10N8 human infections were also lethal. Thus, these events revived the concerns of potential pandemic threats by AIVs in the horizon. This article reviews the various human incursions with AIV variants and provides insight on how continued circulation of these viruses poses perpetual challenge to global public health. As the world anticipates for the next human pandemic, constant vigilance for newly emerging viruses in nature is highly encouraged. With the various numbers of AIVs demonstrating their capacity to breach the animal-human host interface and apparent limitations of current antivirals, there is a need to broaden the selection of pre-pandemic vaccine candidate viruses and development of novel alternative therapeutic strategies.
机译:在过去的几十年中,人们曾观察到甲型流感病毒亚型在接触被感染的家禽后会直接从禽类传人。尽管其中一些菌株引起致命的感染,但缺乏持续的人际传播一直是阻止这些病毒引起新的大流行的主要因素。 2013年,三种(A / H7N9,A / H6N1和A / H10N8)新型禽流感病毒(AIV)再次突破了亚洲的动物-人类宿主物种壁垒。值得注意的是,约有20%的A / H7N9感染患者死于人畜共患病,而3例A / H10N8人类感染中有2例也是致命的。因此,这些事件使人们重新关注了地平线上AIV潜在的大流行威胁。本文回顾了各种带有AIV变体的人类入侵,并提供了有关这些病毒持续传播如何对全球公共卫生构成永久挑战的见解。正如世界对下一次人类大流行的预期一样,强烈建议对自然界中新兴病毒不断保持警惕。随着各种数量的AIV证明其突破动物-人宿主界面的能力和当前抗病毒药的明显局限性,有必要扩大大流行前疫苗候选病毒的选择范围,并开发新的替代治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号